DRKS00003378已完成不适用
Multinational Non-Interventional Study (NIS) of Patients with ST- Segment Elevation Myocardial Infarction Treated with Primary Angioplasty and Concomitant Use of Upstream Antiplatelet Therapy with a Thienopyridine Agent - MULTIPRAC
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,095
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •At least 18 years of age / • Started antiplatelet therapy with a thienopyridine agent upstream based on an initial STEMI diagnosis before arrival at the cathlab hospital according to the authorization of the drug or standard of care. / • Transported to the cathlab (study centre) hospital by ambulance with the intention to perform primary angioplasty (patients can be picked-up from home or from a referring hospital) / • Written informed consent for participation in the NIS / • No current or planned enrolment in a clinical study. Exception: Patients with current or planned enrolment in a clinical study can be included if all of the following conditions are met: a) The patient’s treatment with thienopyridine antiplatelet drugs is not determined by the clinical study protocol but is performed according to the terms of authorization of the drug or standard of care - b) The patient’s actual treatment with antiplatelet drugs and anticoagulants is fully known (i.e. not blinded according to the clinical study protocol).
排除标准
- 未提供
研究者
相似试验
已完成
不适用
A European Non-Interventional Study (NIS) in Patients with Schizophrenia Treated with Antipsychotic Long-Acting Injections (LAIs)F20SchizophreniaDRKS00005466H. Lundbeck A/S654
已完成
2 期
A Comparative Study to evaluate the efficacy of Patha Vidanga Arjuna Dhanvana Kwath with conventional medicine alone in control of â??Metabolic SyndromeCTRI/2022/04/042194Dhanwantarikumar Harinath Jha140
已完成
不适用
A multi-center non-interventional study (NIS) to assess practicability, effectiveness and tolerability of once daily applied tacrolimus formulations used in kidney transplant patients.Immunosuppression after kidney transplantationZ94Transplanted organ and tissue statusDRKS00011124Chiesi GmbH47
进行中（未招募）
2 期
Cabozantinib ePRO studyRenal cell carcinomaJPRN-jRCTs011210055Osawa Takahiro105
进行中（未招募）
1 期
An open label, multicenter, Phase I/II study of pazopanib in combination with paclitaxel in first line treatment of subjects with stage IIIBwet/IV non-small cell lung cancerPart I: Subjects with histologically or cytologically confirmed diagnosis of advanced solid tumours for which there is no standard therapy or for whom paclitaxel is standard therapy. Part II: Stage IIIB wet (with histologically- or cytologically-confirmed malignant pleural effusion) or Stage IV NSCLCMedDRA version: 9.1 Level: LLT Classification code 10029521 Term: Non-small cell lung cancer stage IIIBMedDRA version: 9.1 Level: LLT Classification code 10029522 Term: Non-small cell lung cancer stage IVEUCTR2009-010571-24-GBGlaxoSmithKline Research & Development Limited